The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 02, 2018

Filed:

Nov. 03, 2009
Applicants:

Gilles Bernard Tremblay, La Prairie, CA;

Mario Filion, Longueuil, CA;

Traian Sulea, Kirkland, CA;

Inventors:

Gilles Bernard Tremblay, La Prairie, CA;

Mario Filion, Longueuil, CA;

Traian Sulea, Kirkland, CA;

Assignee:

ADC Therapeutics SA, Epalinges, CH;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/18 (2006.01); C07K 16/30 (2006.01); A61K 31/7088 (2006.01); G01N 33/574 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7088 (2013.01); C07K 16/3038 (2013.01); G01N 33/57449 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/34 (2013.01); C07K 2317/55 (2013.01); C07K 2317/732 (2013.01); C07K 2317/76 (2013.01); C07K 2319/30 (2013.01);
Abstract

Novel monoclonal antibodies that specifically bind to KAAG1 are described. In some embodiments, the antibodies block the biological activity of KAAG1 and are useful in composition in certain cancers, more particularly in cancers that have increased cell surface expression of KAAG1, such as ovarian, renal, lung, colorectal, breast, brain, and prostate cancer, as well as melanoma. The invention also relates to cells expressing the monoclonal antibodies and antigen binding fragments such as humanized and chimeric antibodies. Additionally, methods of detecting and treating cancer using the antibodies and fragments are also disclosed.


Find Patent Forward Citations

Loading…